Eva Pisa
Vermögen: 217 784 $ am 31.05.2026
Vermögen: 217 784 $ am 31.05.2026
Eva Pisa is currently a Member of the Supervisory Board at QIAGEN NV since 2022.
Formerly, Dr. Pisa was Chief Executive Officer at Cepheid AB from 2001 to 2007 and SVP-Roche Centralized & POC Solutions at Roche Diagnostics International AG from 2007 to 2020.
Education includes a doctorate from Karolinska Institutet and an MBA from Heriot-Watt University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2026 | 5’952 ( 0% ) | 217 784 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| QIAGEN N.V. | Direktor/Vorstandsmitglied | 23.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Corporate Officer/Principal | 01.01.2020 |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Health Services |
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen